Elixir Medical Debuts LithiX HC-IVL System In APAC With Breakthrough Procedures In Malaysia

KUALA LUMPUR, April 28 (Bernama) -- Elixir Medical, a developer of disruptive technologies to treat cardiovascular disease, has announced the first clinical use of its LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in the Asia Pacific (APAC) region, marking a significant milestone in the device's global introduction.

According to a statement, the procedures were successfully performed at Cardiac Vascular Sentral Kuala Lumpur Hospital by Dr Tamil Selvan Muthusamy and Dr Rosli Mohd Ali.

“With LithiX, we have developed the first mechanical IVL platform capable of fracturing calcium without requiring an external energy source while avoiding injury to adjacent healthy vessel.

bootstrap slideshow

“The expansion into Malaysia and the greater Asia Pacific region demonstrates global recognition of its unique performance and procedural advantages,” said Elixir Medical Chief Executive Officer, Motasim Sirhan.

Meanwhile, Dr Muthusamy said: “The ability to safely perform complex PCI and treat severe calcium with a mechanical IVL system like LithiX is a significant advancement for our practice and a big win for patients in our region.”

“We are proud to be the first centre in Asia to adopt this innovative technology and demonstrate the excellent clinical outcomes via a live case transmission at the TCTAP congress.”

bootstrap slideshow

The LithiX HC-IVL device represents a novel mechanical approach to calcium modification in calcified coronary lesions, offering the benefits of intravascular lithotripsy using prior technologies without requiring an external energy source.

Based on the Hertz Contact Stress principle, the device delivers precise mechanical amplification of force to achieve calcium fractures while minimising unintended vessel trauma.

The LithiX HC-IVL System features low-profile metal hemispheres integrated on a semi-compliant balloon. When inflated at low pressure, these hemispheres amplify force at contact points with calcium to produce deep and wide fractures, effectively modifying complex calcified lesions while minimising injury to healthy vessel tissue.

-- BERNAMA